WHO: Evidence is lacking for clinical effectiveness of Xevudy and Regen-Cov against the COVID-19 variants that are currently circulating.
Christine Blank
Advertisement
Articles by Christine Blank
Similar symptoms and outcomes among children treated in New York City and London were highlighted during a recent CDC Outreach webinar.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA OKs Subcutaneous Guselkumab Regimen for Ulcerative Colitis: Daily Dose
2
FDA Accepts MannKind sBLA for Inhaled Insulin for Children and Adolescents with Diabetes
3
FDA Approves Updated Indication Statement for Upadacitinib in Inflammatory Bowel Disease Treatment
4
"Shared Decision-Making" for COVID-19 Vaccination Signals "Optional" to Too Many, Says Kelly Moore, MD, MPH
5
